Applied Genetic Technologies Corporation (NASDAQ:AGTC) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, September 13th. Analysts expect the company to announce earnings of $0.14 per share for the quarter.

Applied Genetic Technologies Corporation (NASDAQ:AGTC) opened at 4.50 on Wednesday. Applied Genetic Technologies Corporation has a 12 month low of $4.45 and a 12 month high of $13.35. The stock’s 50 day moving average price is $4.79 and its 200-day moving average price is $5.73. The firm has a market capitalization of $81.34 million, a P/E ratio of 10.74 and a beta of 1.68.

Several research firms have recently issued reports on AGTC. Zacks Investment Research cut shares of Applied Genetic Technologies Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. Cantor Fitzgerald set a $15.00 price objective on shares of Applied Genetic Technologies Corporation and gave the stock a “hold” rating in a research report on Wednesday, May 10th. Stifel Nicolaus decreased their price objective on shares of Applied Genetic Technologies Corporation from $18.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, May 11th. HC Wainwright set a $16.00 price objective on shares of Applied Genetic Technologies Corporation and gave the stock a “buy” rating in a research report on Saturday, June 10th. Finally, ValuEngine cut shares of Applied Genetic Technologies Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company has an average rating of “Buy” and an average target price of $13.81.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://theolympiareport.com/2017/09/06/applied-genetic-technologies-corporation-agtc-set-to-announce-quarterly-earnings-on-wednesday.html.

Applied Genetic Technologies Corporation Company Profile

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP).

Earnings History for Applied Genetic Technologies Corporation (NASDAQ:AGTC)

Receive News & Ratings for Applied Genetic Technologies Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Genetic Technologies Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.